SL Science Holding Ltd (SLBT) stock
SLBTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 18, 2026
$0.64−0.08 (-11.73%)
Close on Nov 17, 2026Market cap $356.14MP/E –Yield –
SL Science ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for SL Science
SL Science has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?